Cardiovascular manifestations of HIV infection

被引：132

作者：

Barbaro, G ^{[1
]}

机构：

[1] Univ Roma La Sapienza, Dept Med Pathophysiol, Rome, Italy

来源：

CIRCULATION | 2002年 / 106卷 / 11期

关键词：

D O I：

10.1161/01.CIR.0000031704.78200.59

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1420 / 1425

页数：6

共 35 条

[1]

Abad C, 2000, TEX HEART I J, V27, P356

[2] Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension [J].

Aguilar, RV ;

Farber, HW .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (05) :1846-1850

[3] Hypertension in the HIV-infected patient [J].

Aoun S. ;

Ramos E. .

Current Hypertension Reports, 2000, 2 (5) :478-481

[4] Cardiac involvement in the acquired immunodeficiency syndrome: A multicenter clinical-pathological study [J].

Barbaro, G ;

Di Lorenzo, G ;

Grisorio, B ;

Barbarini, G .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (12) :1071-1077

[5]

Barbaro G, 2001, Lancet Infect Dis, V1, P115, DOI 10.1016/S1473-3099(01)00067-6

[6] HIV-associated coronary arteritis in a patient with fatal myocardial infarction [J].

Barbaro, G ;

Barbarini, G ;

Pellicelli, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (23) :1799-1800

[7] RETRACTED: Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-α and nitric oxide synthase (Retracted Article. See vol 18, pg 1087, 2004) [J].

Barbaro, G ;

Di Lorenzo, G ;

Soldini, M ;

Giancaspro, G ;

Grisorio, B ;

Pellicelli, AM ;

D'Amati, G ;

Barbarini, G .

AIDS, 2000, 14 (07) :827-838

[8] Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy [J].

Barbaro, G ;

Di Lorenzo, G ;

Soldini, M ;

Giancaspro, G ;

Grisorio, B ;

Pellicelli, A ;

Barbarini, G .

CIRCULATION, 1999, 100 (09) :933-939

[9]

Barbaro Giuseppe, 2002, AIDS Reviews, V4, P93

[10] Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance [J].

Carr, A ;

Samaras, K ;

Chisholm, DJ ;

Cooper, DA .

LANCET, 1998, 351 (9119) :1881-1883

← 1 2 3 4 →